Sharenet Sites 
Sharenet Sites
JCD - JCI Limited - Notification to JCI shareholders JCI LIMITED (Incorporated in the Republic of South Africa) Registration number 1894/00854/06 Share code: JCD ISIN: ZAE0000039681 (Suspended) ("JCI" or "the company") NOTIFICATION TO JCI SHAREHOLDERS Shareholders of JCI Limited ("JCI") have been informed that Hemispherx Biopharma Incorporated (a United States based pharmaceutical company) ("Hemispherx") obtained a judgment against JCI in the United States on 11 August 2010 for an amount of US $188 492 319. JCI on the advice of its legal advisors took a limited part in the abovementioned proceedings on various preliminary bases including the jurisdiction of the United States Court. Following the Court`s ruling on jurisdiction, JCI on the recommendation of its legal advisors withdrew from the case. Hemispherx is now seeking enforcement of this judgment in South Africa and on 28 June 2011 it served an application on JCI to this effect. JCI will be vigorously opposing the application. JCI shareholders are advised to continue to exercise caution when trading in their shares in terms of the cautionary announcement dated 28 June 2011. Johannesburg 6 July 2011 Sponsor: Investec Bank Limited Date: 06/07/2011 15:00:02 Supplied by www.sharenet.co.za Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited (`JSE`). The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on, information disseminated through SENS.
